Provider QP35-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 14, 2022 - Opens in a new window Read More - Opens in a new window
Provider OTC Covid-19 At Home Test Quantity Limit - Medicaid - Opens in a new window Read More - Opens in a new window
Provider QP24-22 Join the TruHearing Audiology and Hearing Aid Network - Opens in a new window Read More - Opens in a new window
Provider QP25-22 Reminder for New to Market Medical Drugs: Medical Drug Evaluation Process List - Opens in a new window Read More - Opens in a new window
Provider QP26-22 Provider Directory Validation (PDV) Tool - Opens in a new window Read More - Opens in a new window
Provider QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro - Opens in a new window Read More - Opens in a new window
Provider QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib) - Opens in a new window Read More - Opens in a new window
Provider QP29-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TavneosTM (avacopan) - Opens in a new window Read More - Opens in a new window
Provider QP30-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TyrvayaTM (varenicline) - Opens in a new window Read More - Opens in a new window
Provider P17-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements - Opens in a new window Read More - Opens in a new window